Next, we performed a bone marrow transfer (BMT) experiment that confined SERT deficiency to immune cells by reconstituting B6 recipient mice with bone marrow (BM) cells from either Sert-WT or Sert-KO donor mice, followed by B16-OVA tumor challenge (Figure 3E). Here, SLC6A4 is linked to neoplasm.